Showing results (41-50 of 54) with videos related to

Sort By:
Pageof 6
Actas Urologicas Espanolas|April 30, 2015
External validation of FXYD3 and KRT20 as predictive biomarkers for the presence of micrometastasis in muscle invasive bladder cancer lymph nodesM Ramírez-Backhaus, A Fernández-Serra, J Rubio-Briones, et al.
Actas Urologicas Espanolas|April 20, 2016
Association between late-onset hypogonadism syndrome plus metabolic syndrome and prostate cancer and its aggressivenessJ Fuentes-Pastor, P Pellejero, I Ortiz, et al.
Archivos Espanoles De Urologia|June 25, 2013
[Non-invasive diagnosis of prostate cancer: serum and urine markers]J Rubio-Briones, I Casanova-Casas, A Fernández-Serra, et al.
Actas Urologicas Espanolas|June 11, 2002
[Assessment of the basal membrane status as prognostic factor in renal carcinoma]J Rubio Briones, L Morell Quadreny, J A López Guerrero, et al.
Actas Urologicas Espanolas|January 25, 2011
[Immunohistochemical expression of microvascular density and carbonic anhidrase IX in renal carcinoma. Relation to histological type and tumoral progression]J Rubio-Briones, A Calatrava, A Fernández-Serra, et al.
Actas Urologicas Espanolas|June 9, 2019
Undetectable PSA after radical prostatectomy is more likely in low burden N+ prostate cancer patients when an extended lymph node dissection is performedM Ramírez-Backhaus, M C Mir Maresma, J M Mascarós, et al.
Actas Urologicas Espanolas|July 22, 2004
[Usefulness of serum markers in renal cell carcinoma]J Rubio Briones, I Iborra Juan, E Aznar, et al.
Actas Urologicas Espanolas|March 27, 2017
PCA3 as a second-line biomarker in a prospective controlled randomized opportunistic prostate cancer screening programmeJ Rubio-Briones, J Casanova, F Martínez, et al.
Actas Urologicas Espanolas|June 25, 2011
[Outcomes of expanded use of PCA3 testing in a Spanish population with clinical suspicion of prostate cancer]J Rubio-Briones, A Fernández-Serra, M Ramírez, et al.
Actas Urologicas Espanolas|June 28, 2015
Preliminary results of the Spanish Association of Urology National Registry in Active Surveillance for prostate cancerJ Rubio-Briones, A Borque, L M Esteban, et al.
Pageof 6